A detailed history of Long Run Wealth Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Long Run Wealth Advisors, LLC holds 46,085 shares of PFE stock, worth $1.29 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
46,085
Previous 39,964 15.32%
Holding current value
$1.29 Million
Previous $1.12 Million 19.23%
% of portfolio
0.32%
Previous 0.29%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$27.7 - $31.39 $169,551 - $192,138
6,121 Added 15.32%
46,085 $1.33 Million
Q2 2024

Jul 19, 2024

BUY
$25.26 - $29.6 $77,598 - $90,931
3,072 Added 8.33%
39,964 $1.12 Million
Q1 2024

Apr 24, 2024

BUY
$25.89 - $29.73 $78,317 - $89,933
3,025 Added 8.93%
36,892 $1.02 Million
Q4 2023

Jan 10, 2024

BUY
$26.13 - $33.94 $40,684 - $52,844
1,557 Added 4.82%
33,867 $975,000
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $42,615 - $49,813
1,328 Added 4.29%
32,310 $1.07 Million
Q2 2023

Jul 17, 2023

BUY
$36.12 - $41.79 $36,950 - $42,751
1,023 Added 3.41%
30,982 $1.14 Million
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $60,699 - $79,022
1,541 Added 5.42%
29,959 $1.22 Million
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $27,555 - $35,970
-660 Reduced 2.27%
28,418 $0
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $212,279 - $259,140
4,851 Added 20.02%
29,078 $1.27 Million
Q2 2022

Jul 19, 2022

SELL
$46.53 - $55.17 $6,653 - $7,889
-143 Reduced 0.59%
24,227 $1.27 Million
Q1 2022

Apr 27, 2022

SELL
$45.75 - $56.69 $49,913 - $61,848
-1,091 Reduced 4.28%
24,370 $1.26 Million
Q4 2021

Jan 21, 2022

BUY
$41.32 - $61.25 $1.05 Million - $1.56 Million
25,461 New
25,461 $1.5 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Long Run Wealth Advisors, LLC Portfolio

Follow Long Run Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Run Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Run Wealth Advisors, LLC with notifications on news.